Anixa Biosciences Inc — Director's Dealing 2021

Jun 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anixa Biosciences Inc (ANIX)
CIK: 0000715446
Period of Report: 2021-06-01

Reporting Person: Titterton Lewis H jr (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-01	Employee Stock Option (Right to Buy)	$4.02	A	30000	Acquired	2031-06-01	Common Stock (30000)	Direct
2021-06-01	Employee Stock Option (Right to Buy)	$4.02	A	200000	Acquired	2031-06-01	Common Stock (200000)	Direct

Footnotes

F1: Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.

F2: The options vest and become exercisable in twelve (12) equal monthly installments beginning June 30, 2021.

F3: The options vest and become exercisable in thirty-six (36) equal monthly installments beginning June 30, 2021.